rs2070997

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_005157.6(ABL1):​c.908-164A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.129 in 152,234 control chromosomes in the GnomAD database, including 1,416 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.13 ( 1416 hom., cov: 33)

Consequence

ABL1
NM_005157.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.06

Publications

8 publications found
Variant links:
Genes affected
ABL1 (HGNC:76): (ABL proto-oncogene 1, non-receptor tyrosine kinase) This gene is a protooncogene that encodes a protein tyrosine kinase involved in a variety of cellular processes, including cell division, adhesion, differentiation, and response to stress. The activity of the protein is negatively regulated by its SH3 domain, whereby deletion of the region encoding this domain results in an oncogene. The ubiquitously expressed protein has DNA-binding activity that is regulated by CDC2-mediated phosphorylation, suggesting a cell cycle function. This gene has been found fused to a variety of translocation partner genes in various leukemias, most notably the t(9;22) translocation that results in a fusion with the 5' end of the breakpoint cluster region gene (BCR; MIM:151410). Alternative splicing of this gene results in two transcript variants, which contain alternative first exons that are spliced to the remaining common exons. [provided by RefSeq, Aug 2014]
ABL1 Gene-Disease associations (from GenCC):
  • congenital heart defects and skeletal malformations syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P
  • connective tissue disorder
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • bone development disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.173 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABL1NM_005157.6 linkc.908-164A>G intron_variant Intron 5 of 10 ENST00000318560.6 NP_005148.2 P00519-1A0A024R8E2Q59FK4
ABL1NM_007313.3 linkc.965-164A>G intron_variant Intron 5 of 10 NP_009297.2 P00519-2Q59FK4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABL1ENST00000318560.6 linkc.908-164A>G intron_variant Intron 5 of 10 1 NM_005157.6 ENSP00000323315.5 P00519-1
ABL1ENST00000372348.9 linkc.965-164A>G intron_variant Intron 5 of 10 1 ENSP00000361423.2 P00519-2

Frequencies

GnomAD3 genomes
AF:
0.129
AC:
19651
AN:
152116
Hom.:
1413
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.177
Gnomad AMI
AF:
0.0691
Gnomad AMR
AF:
0.150
Gnomad ASJ
AF:
0.0948
Gnomad EAS
AF:
0.0620
Gnomad SAS
AF:
0.0935
Gnomad FIN
AF:
0.0709
Gnomad MID
AF:
0.0981
Gnomad NFE
AF:
0.115
Gnomad OTH
AF:
0.126
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.129
AC:
19677
AN:
152234
Hom.:
1416
Cov.:
33
AF XY:
0.126
AC XY:
9351
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.177
AC:
7341
AN:
41512
American (AMR)
AF:
0.150
AC:
2300
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0948
AC:
329
AN:
3472
East Asian (EAS)
AF:
0.0621
AC:
322
AN:
5182
South Asian (SAS)
AF:
0.0940
AC:
453
AN:
4820
European-Finnish (FIN)
AF:
0.0709
AC:
752
AN:
10612
Middle Eastern (MID)
AF:
0.0850
AC:
25
AN:
294
European-Non Finnish (NFE)
AF:
0.115
AC:
7822
AN:
68022
Other (OTH)
AF:
0.128
AC:
270
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
867
1735
2602
3470
4337
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
220
440
660
880
1100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.125
Hom.:
2250
Bravo
AF:
0.137
Asia WGS
AF:
0.106
AC:
368
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.0030
DANN
Benign
0.33
PhyloP100
-2.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2070997; hg19: chr9-133748083; API